Statistical Biomarker Validation
IDDI Accelerates Your Statistical Biomarker Validation
IDDI has experience in the identification and statistical biomarker validation of diagnostic utility, prognostic and/or predictive ability, and those that can potentially be used as surrogate endpoints in clinical trials.
IDDI Expertise in Statistical Biomarker Validation:
We have developed a Bayesian approach to accelerate the development and validation of Biomarkers. We take advantage of Bayesian statistical methods, which can incorporate prior knowledge and integrate different sources of information, in combination with adaptive design concepts, which tailor features based on ongoing information.
Our expertise can help you develop diagnostic, prognostic, predictive and surrogate biomarkers faster and cheaper.
TO ACCESS OUR SERVICE FLYER PLEASE FILL OUT THE FORM BELOW